Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.36 |
| ▸ | TLR4 | O00206 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8741460 | 0.81 | TLR4 (0.34) | TLR4CYP19A1 | |
| SCHEMBL6595832 | 0.79 | — | — | |
| SCHEMBL821855 | 0.78 | — | — | |
| SCHEMBL11702792 | 0.78 | — | — | |
| SCHEMBL6239420 | 0.77 | TDO2 (0.31) | — | |
| SCHEMBL31285765 | 0.76 | KDM1A (0.40) | TLR4KDM1AKDM4EPOLBL3MBTL1 | |
| Hydrazine SCHEMBL1572402 | 0.75 | KDM1A (0.30) | KDM1A | |
| SCHEMBL1821880 | 0.73 | — | — | |
| SCHEMBL6811753 | 0.73 | KDM1A (0.34) | KDM1A | |
| SCHEMBL19003295 | 0.73 | KDM4E (0.31) | ESR1ESR2KDM4EPOLBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5122498-A | Hydrogenated phenanthrene and anthracene as solvents for leuco dyes; high dissolving power | NKK CORPORATION (JP) | 1992-06-16 | — | — | US | claimed |
| US-20230009398-A1 | NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF | Ústav organické chemie a biochemie AV CR, v.v.i. (CZ) | 2023-01-12 | — | — | US | disclosed |
| EP-3692015-B1 | NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF | UNIV JOHNS HOPKINS (US) | 2022-08-24 | — | — | EP | disclosed |
| CN-110418808-B | Photocrosslinkable polymer, insulating film, planarizing film, lyophilic-lyophilic patterned film, and organic field effect transistor device comprising same | 东曹株式会社 | 2022-07-15 | — | — | CN | disclosed |
| CN-111100707-B | Hydrocracking method for producing chemical material and fuel oil | 中国石油化工股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-111100706-B | Hydrocracking method for producing fuel oil | 中国石油化工股份有限公司 | 2022-04-08 | — | — | CN | disclosed |
| CN-110540875-B | Process for producing high density jet fuel and clean diesel | 中国石油化工股份有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-111117699-B | Hydrogenation method for producing high-quality jet fuel | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-111117700-B | Method for producing heavy naphtha and jet fuel | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| CN-111117702-B | Hydrocracking method for increasing yield of heavy naphtha and jet fuel fraction | 中国石油化工股份有限公司 | 2022-01-04 | — | — | CN | disclosed |
| US-7067179-B1 | Fused ring compound | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-06-27 | — | — | US | disclosed |
| EP-1201632-B1 | FUSED RING COMPOUND | DAINIPPON INK & CHEMICALS (JP) | 2006-03-29 | — | — | EP | disclosed |
| EP-1201632-A1 | FUSED RING COMPOUND | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2002-05-02 | — | — | EP | disclosed |
| WO-1999020267-A1 | FURANYL, TETRACYCLIC TRITERPENE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5122498-A | Hydrogenated phenanthrene and anthracene as solvents for leuco dyes; high dissolving power | NKK CORPORATION (JP) | 1992-06-16 | — | — | US | disclosed |
| WO-1990003353-A1 | LIQUID PHASE FLUORINATION | EXFLUOR RESEARCH CORPORATION (US) | 1990-04-05 | — | — | WO | disclosed |
| EP-0307941-A2 | Microcapsules of pressure-sensitive copying paper | NKK CORPORATION (JP) | 1989-03-22 | — | — | EP | disclosed |
| EP-0304809-A1 | Perfluorinated butyl derivative compounds | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1989-03-01 | — | — | EP | disclosed |
| EP-0063052-A2 | Starting pitches for carbon fibers | NIPPON OIL CO. LTD. (JP) | 1982-10-20 | — | — | EP | disclosed |
| US-4337142-A | USE OF PRODUCT FRACTION AS HYDROGEN-DONOR SOLVENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) | 1982-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230009398-A1 | NOVEL GLUTAMINE ANTAGONISTS AND USES THEREOF | GLUL, PDCD1, CD274 | ESR1 4123/4885ESR2 4259/4885TLR4 1230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.